Stay updated on Pembrolizumab for Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. This appears to be a metadata/versioning update with no visible changes to study details or page content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 added and a general funding-status notice was removed; these site-wide changes do not affect study content or participation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedAdded a global site notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a glossary toggle and introduced the labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision now shows v3.4.0 and the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.